Skip to main content

Welcome to our new website. We’re still fine-tuning things. If you experience any issues or would like to provide feedback, please contact us.

Joshua
M.
Sharfstein
,
MD

Vice Dean for Public Health Practice and Community Engagement
Professor of the Practice

Joshua Sharfstein, MD, works to develop and promote public health strategies, healthcare payment approaches, and regulatory policies that advance health and equity.

Contact Info

615 N. Wolfe Street, Room W1033D
Baltimore
Maryland
21205
US        
Experiences & Accomplishments
Education
MD
Harvard Medical School
1996
Overview

Dr. Sharfstein is Vice Dean for Public Health Practice and Community Engagement, director of the Bloomberg American Health Initiative, and Professor of the Practice in Health Policy and Management. Previously, he served as the Secretary of the Maryland Department of Health and Mental Hygiene, the Principal Deputy Commissioner of the U.S. Food and Drug Administration, as Commissioner of Health for Baltimore City, and as health policy advisor for Congressman Henry A. Waxman. He is an elected member of the National Academy of Medicine and the National Academy of Public Administration.

Honors & Awards

2018 Advising, Mentoring, Teaching, Recognition Award, JHSPH 2013 Circle of Commendation Award, Consumer Product Safety Commission 2008 Public Official of the Year, Governing Magazine 1999 Alpha Omega Alpha, Boston University School of Medicine 1996 Rose Seegal Award for Research, Community Service Award, Robert H. Ebert Prize in Primary Care, Harvard Medical School 1994 Jay S. Drotman Memorial Award, American Public Health Association

Select Publications

I have written on a wide range of public health topics. Here are a few examples.

  • Sharfstein JM, Gerovich S, Chin D. Global Budgets for Safety-Net Hospitals. Journal of the American Medical Association. 2017 Nov 14;318(18):1759-1760.

  • Sharfstein JM. A New Year's Wish on Opioids. JAMA. 2018 Feb 13;319(6):537-538.

  • Olsen Y, Sharfstein J. Confronting the stigma of opioid use disorder—and its treatment. Journal of the American Medical Association 2014; 311: 1393-4.

  • Sharfstein JM. The FDA--a misunderstood agency. Journal of the American Medical Association 2011; 306:1250-1.

  • Sharfstein J and Sharfstein SS. Campaign contributions from the American Medical Political Action Committee to members of Congress: For or against the public health? New England Journal of Medicine.1994; 330: 32–37. Correction: 332:1450.

Projects
A Blueprint for Transforming Opioid Use Disorder Treatment in Delaware